HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of microcirculatory parameters to evaluate clinical treatments of chronic venous disorder (CVD).

AbstractOBJECTIVES:
To evaluate changes on cutaneous microangiopathy in chronic venous disorder (CVD) after use of Cirkan [venotonic drug containing Ruscus aculeatus (plant extract), hesperidine methylchalcone (flavonoid) and vitamin C], elastic compression stockings (ECS) or no treatment for four weeks.
PATIENTS AND METHODS:
Fifty-five female patients (85 legs), 25 to 57 years, with at least one limb classified as C2,s or C2,3,s (CEAP classification), were allocated consecutively, according to entrance order, in these three groups. Ten healthy women age-matched were also investigated. Using orthogonal polarization spectral technique (noninvasive method), measurements of functional capillary density (FCD, number of capillaries with flowing red blood cells/mm(2)), capillary morphology (CM, % of abnormal capillaries/mm(2)) and diameters (mum) of dermal papilla (DDP), capillary bulk (DCB) and capillary limb (CD) were obtained on the medial perimalleolar region and later analyzed using CapImage software.
RESULTS AND CONCLUSIONS:
CVD patients showed significant changes on CD and CM compared to healthy subjects in agreement with our previous findings (J Vasc Surg 43:1037-1044, 2006). On Cirkan-treated patients, after 4 weeks, CD decreased on both limbs and CM improved on the left one, suggesting an amelioration of the chronic venous hypertension. No significant changes could be detected on other patient groups. These results confirm the existence of microcirculatory dysfunction in early stages of CVD, probably due to post-capillary hypertension, and further support the venotonic action of Cirkan.
AuthorsCarmen Lucia Lascasas-Porto, Ana Letícia M Milhomens, Carlos Eduardo Virgini-Magalhães, Fabiano F A Fernandes, Fernando L Sicuro, Eliete Bouskela
JournalMicrovascular research (Microvasc Res) Vol. 76 Issue 1 Pg. 66-72 (May 2008) ISSN: 1095-9319 [Electronic] United States
PMID18423497 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Drug Combinations
  • Phytosterols
  • Plant Extracts
  • hesperidine methylchalcone, ruscus aculeatus, vitamin C
  • Hesperidin
  • Chymotrypsin
  • Trypsin
  • Ascorbic Acid
Topics
  • Adult
  • Ascorbic Acid (therapeutic use)
  • Capillaries (pathology, physiopathology)
  • Chymotrypsin (therapeutic use)
  • Combined Modality Therapy
  • Drug Combinations
  • Edema (pathology, therapy)
  • Female
  • Hesperidin (therapeutic use)
  • Humans
  • Leg (pathology, physiopathology)
  • Microcirculation (physiopathology)
  • Middle Aged
  • Phytosterols (therapeutic use)
  • Plant Extracts (therapeutic use)
  • Stockings, Compression
  • Treatment Outcome
  • Trypsin (therapeutic use)
  • Venous Insufficiency (pathology, physiopathology, therapy)
  • Venous Thrombosis (pathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: